Elsevier

Atherosclerosis

Volume 92, Issue 1, January 1992, Pages 41-47
Atherosclerosis

Research paper
Lipoprotein Lp(a) levels are reduced by danazol, an anabolic steroid

https://doi.org/10.1016/0021-9150(92)90008-5Get rights and content

Abstract

Serum levels of lipids, lipoproteins and apolipoprotems were measured in 26 premenopausal women with endometriosis both before and after six months therapy with the anabolic steroid danazol (600 mg/day) and in 15 untreated women who acted as controls. No changes were seen in the control group over six months. In women treated with danazol, mean levels of low density lipoprotein (LDL) cholesterol increased by 36% while those of high density lipoprotein (HDL) cholesterol decreased by 46%, changes characteristic of androgenic steroids. In contrast to this potentially detrimental lipoprotein profile, lipoprotein(a) [Lp(a)) levels were reduced by 78.6% ± 24.0% (mean ± S.D.) in women taking danazol. These dramatic changes in Lp(a) levels correlated with baseline Lp(a) levels but not with changes in LDL or HDL. Anabolic steroids such as danazol appear to be powerful modulators of serum Lp(a) concentrations. This could be due to direct effects on Lp(a) metabolism, or secondary to the effects of these steroids on insulin metabolism or on the coagulation and fibrinolysis system.

References (31)

  • G. Utermann

    The mysteries of lipoprotein (a)

    Science

    (1989)
  • K. Berg

    A new serum type system in man — the LP-system

    Acta. Pathol. Microbiol. Scand.

    (1963)
  • J.W. McLean et al.

    cDNA sequence of human apolipoprotein (a) is homologous to plasminogen

    Nature

    (1987)
  • L.E. Carlson et al.

    Pronounced lowering of serum levels of lipoprotein Lp(a) in hyperlipidaemic subjects treated with nicotinic acid

    J. Intern. Med.

    (1989)
  • V. Wynn

    Metabolic effects of danazol

    J. Int. Med. Res.

    (1977)
  • Cited by (111)

    • Anabolic steroid excess and myocardial infarction: From ischemia to reperfusion injury

      2020, Steroids
      Citation Excerpt :

      Indeed, dyslipidemia was observed after three days of administration of stanozolol at 6 mg/day, while the effect on triglyceride lipase emerged after only one day of administration [34]. Over time, LDL/HDL can also be enhanced by AS effects on apolipoproteins (Apo) levels [30,33–35]. Circulating Apo-A1 and Apo-D, both components of HDL, have been shown to be down-regulated in AS users under the administration of nandrolone decanoate at 200 mg/wk for eight weeks [36].

    • Lipoprotein(A)

      2009, Clinical Lipidology: A Companion to Braunwald's Heart Disease
    • Lipoprotein(a)

      2008, Clinical Lipidology: A Companion to Braunwald's Heart Disease Expert Consult: Online and Print
    View all citing articles on Scopus
    View full text